The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 344:776-777 March 8, 2001 Number 10
NextNext

MRI-Guided Diagnosis and Treatment of Prostate Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: In the United States, the most common method for diagnosing prostate cancer is a transrectal ultrasound-guided needle biopsy of the prostate gland. However, the positive predictive value of this method is only 18 percent.1 We used a real-time, intraoperative magnetic resonance imaging (MRI) guidance system (General Electric, Milwaukee)2 to diagnose and treat prostate cancer in a 62-year-old man with a rising prostate-specific antigen level. The patient was not a candidate for a transrectal ultrasound-guided prostate biopsy because of a previous proctocolectomy for ulcerative colitis.

For the diagnosis, we used a real-time, intraoperative 0.5-T MRI system2 and a . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.